ScholarIQanswers from OpenAlex
Neurological and metabolic disorders
TopicLeading institutions, researchers & key papers
Neurological and metabolic disorders is a topic indexed in ScholarIQ from OpenAlex.
What is known about Neurological and metabolic disorders?
ScholarIQrecord summary
This cluster of papers focuses on the association between hyperglycemia, basal ganglia lesions, and various movement disorders such as chorea, hemichorea-hemiballismus, and seizures. It explores the clinical manifestations, neuroimaging findings, differential diagnosis, and management of hyperglycemic chorea and related conditions in patients with diabetes or uremia.
How many works does Neurological and metabolic disorders have?
ScholarIQindexed works
Neurological and metabolic disorders has 82 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Neurological and metabolic disorders?
ScholarIQopenalex
The OpenAlex for Neurological and metabolic disorders is on the source record.
What are the most-cited papers on Neurological and metabolic disorders?
ScholarIQmost cited works
Diagnosis and Management of the Metabolic Syndrome
Scott M. Grundy, James I. Cleeman, Stephen R. Daniels, Karen A. Donato, Robert H. Eckel, Barry A. Franklin, David J. Gordon, Ronald M. Krauss, Peter J. Savage, Sidney C. Smith, John A. Spertus, Fernando Costa
NEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES1
Jaime A. Davidson, Alan Wilkinson, Jacques Dantal, Francesco Dotta, Hermann Haller, Domingo Hernández, Bertram L. Kasiske, Bryce Kiberd, Andrew J. Krentz, Christophe Legendre, Piero Marchetti, Mariana Markell, Fokko J. van der Woude, David C. Wheeler
Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images
Fernando Cendes, Frédérick Andermann, Mark C. Preul, Douglas L. Arnold
Progressive Supranuclear Palsy
John C. Steele
The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors?
Anne C. Hesp, Jennifer A. Schaub, Pottumarthi V. Prasad, Volker Vallon, Gozewijn D. Laverman, Petter Bjornstad, Daniël H. van Raalte
Where is Neurological and metabolic disorders research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Neurological and metabolic disorders is open access?
ScholarIQopen access share
33%OPEN ACCESS